HTA & Reimbursement

Terms for how health technology assessment bodies appraise new technologies and reach funding decisions.

  • Topic: HTA & Reimbursement
  • 43 terms
  • Editor reviewed

33–40 of 43 terms

Public ConsultationPublic Comment Process, Citizen Consultation, Public Consultation HTA, Public Engagement

A formal process inviting stakeholder and public comments on a draft recommendation before it is finalised.

ReassessmentRe-Evaluation, Renewed Review

A subsequent assessment of a previously reviewed technology, undertaken to incorporate new evidence or reconsider a decision given changed circumstances.

Reference CaseStandard Analytic Case, Base-Case Methods Standard

A reference case is a documented set of preferred methodological choices that an institution asks analysts to follow so economic evaluations are transparent, consistent and comparable for a defined decision context.

Reimbursement DecisionCoverage Verdict, Reimbursement Verdict

The formal determination by a payer regarding whether, and under what conditions, a technology will be financially covered for a population.

Rule of RescueRescue Principle, Identifiable Victim Effect

An ethical intuition describing the strong societal impulse to devote resources to rescuing identifiable individuals in immediate danger, even against cost-effectiveness logic.

ScopingScoping Phase, Scope Definition

The initial assessment stage in which the specific boundaries, including technology, population, comparators, and outcomes, are formally defined.

Single Technology AssessmentSTA, Single-Product Appraisal

An assessment process focused on a single specific technology, typically a newly launched drug, unlike a multiple technology assessment.

SMCScottish Medicines Consortium, Scotland HTA

The Scottish Medicines Consortium, advising Scotland's NHS boards on the clinical and cost-effectiveness of newly licensed medicines for local formulary decisions.